(Updates, including stock activity)
** Inari Medical NARI.O shares tumble 16.4% to $81.83
early Thurs as co seeks equity
** Stock on course for record one-day pct decline. Biggest
fall was 15.5% drop on Aug 11, 2021
** Seller of devices to remove blood clots commenced 2 mln
share offering urn:newsml:reuters.com:*:nGNX20YJ8s
** BofA and Morgan Stanley joint lead bookrunners
** NARI has ~50.6 mln shares outstanding for roughly $5 bln
market cap, per Refinitiv data
** Through close on Weds, shares gained 32% over the past
month
** On Feb 23, co reported Q4 rev of $83 mln (up 71% yr/yr)
and forecasted FY 2022 rev of $350-$360 mln, reflecting approx
28% growth at the midpoint over 2021 urn:newsml:reuters.com:*:nGNX5R70cp
** Wall Street firmly bullish on NARI with avg rating of
"strong buy"; median PT is $105 - Refinitiv
** NARI went public in May 2020 IPO priced at $19
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))